A multi-specific multi-functional CD4+ T cell therapy for solid tumors for superior safety and efficacy in immunotherapy
Time: 1:05 pm
day: Conference Day Two
Details:
• A distinct type of CD4+ T cells in tumor immunity—CD4 CTLs with both cytotoxicity and helper functions
• Producing CD4 CTLs with natural TCRs targeting multiple antigens for immunotherapy in solid tumors
• Multi-specific CD4 CTLs are poised for superior safety and efficacy in immunotherapy
